Alpha 2.0
Login Register
» Articles » PMID: 12849260

Alexander Disease: GFAP Mutations Unify Young and Old

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2003 Jul 10
PMID 12849260
Citations 4
Authors
Albee Messing
Michael Brenner
Affiliations
Soon will be listed here.
Citing Articles

Elevated MeCP2 in Mice Causes Neurodegeneration Involving Tau Dysregulation and Excitotoxicity: Implications for the Understanding and Treatment of MeCP2 Triplication Syndrome.

Montgomery K, Louis Sam Titus A, Wang L, DMello S Mol Neurobiol. 2018; 55(12):9057-9074.

PMID: 29637441 PMC: 6477919. DOI: 10.1007/s12035-018-1046-4.

The clinical spectrum of late-onset Alexander disease: a systematic literature review.

Balbi P, Salvini S, Fundaro C, Frazzitta G, Maestri R, Mosah D J Neurol. 2010; 257(12):1955-62.

PMID: 20721574 DOI: 10.1007/s00415-010-5706-1.

Dysfunctions of neuronal and glial intermediate filaments in disease.

Liem R, Messing A J Clin Invest. 2009; 119(7):1814-24.

PMID: 19587456 PMC: 2701870. DOI: 10.1172/JCI38003.

GFAP and its role in Alexander disease.

Quinlan R, Brenner M, Goldman J, Messing A Exp Cell Res. 2007; 313(10):2077-87.

PMID: 17498694 PMC: 2702672. DOI: 10.1016/j.yexcr.2007.04.004.